Yayınlar & Eserler

Yayın Ağı
Makaleler 61
Tümü (61)
SCI-E, SSCI, AHCI (53)
SCI-E, SSCI, AHCI, ESCI (56)
ESCI (3)
Scopus (58)
TRDizin (2)
Diğer Yayınlar (1)

1. A rare disease with many faces: a multicentre registry of IgG4-related disease in children

KAYA AKCA Ü., KÖSE H., Kurt T., Ulu K., Guliyeva V., Kilbas G., et al.
RHEUMATOLOGY , sa.4, ss.2185-2192, 2025 (SCI-Expanded, Scopus) identifier identifier

2. Idiopathic polyarteritis nodosa-does it still exist? Viewpoint 2: idiopathic polyarteritis nodosa is rare, but still exists

KARADAĞ Ö.
RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus) identifier identifier

3. Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter Study

Di Matteo A., Di Donato S., Smerilli G., Becciolini A., Camarda F., Cauli A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.22-33, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

4. Commentary on IgG4-related uveitis. A French cohort and literature review

EKİCİ M., KADAYIFÇILAR S., BEZCİ AYGÜN F., KARADAĞ Ö.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.69, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

5. Long-term follow-up of anti-TNF treatment in adult and pediatric DADA2 patients: Insights from real-world data

AYAN G., BAŞARAN H. Ö., FIRLATAN B., KILIÇ L., BİLGİNER Y., ALİKAŞİFOĞLU M., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.27, sa.11, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

6. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies

Uzun G. S., GÖKÖZ Ö., ÖĞÜT B., HEPER A., Guresci S., KARDAŞ R. C., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.44, ss.2547-2554, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

7. Factors Associated with the Development of Anti-drug Antibodies to TNFi and the Consequences for Axial Spondyloarthritis: A Two-year Follow-up Study

Ediboglu E. D., Cinar M., KOZACI L. D., SOLMAZ D., Sargin G., KARADAĞ Ö., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.11, sa.3, ss.364-370, 2024 (ESCI, TRDizin) identifier identifier identifier

8. Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry

SARIYILDIZ E., ÜNALDI E., KILIÇ L., KARADAĞ Ö., KALYONCU U., ERTENLİ A. İ., et al.
Acta Medica , cilt.55, sa.3, ss.214-221, 2024 (TRDizin) identifier

9. Orbital Pseudotumor in Granulomatosis with Polyangiitis. Interim Analysis of Clinical Outcomes from a European Collaborative Observational Study

Moroni L., Gallina G., Lanzillotta M., Maggioni S., Benanti G., Cariddi A., et al.
ARTHRITIS & RHEUMATOLOGY , ss.5054-5057, 2024 (SCI-Expanded, Scopus) identifier

10. Assessment of venous disease with different venous disease specific scales in Behçet's disease patients with deep vein thrombosis

AKSOY A., Colak S., YAĞIZ B., COŞKUN B. N., Omma A., SARI A., et al.
PHLEBOLOGY , cilt.39, ss.550-556, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study

Bahap-Kara M., SARIYILDIZ E., YARDIMCI G. K., KARADAĞ Ö., EKİNCİOĞLU A.
RHEUMATOLOGY AND THERAPY , cilt.11, sa.4, ss.1043-1055, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

12. IMMUNOGLOBULIN G4-RELATED THORACIC DISEASE: CLINICAL AND RADIOLOGICAL FINDINGS OF A TURKISH COHORT

Alkan A., DURHAN G., YARDIMCI G. K., Sertcelik U. O., Farisogullari B., Ariyurek M., et al.
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.41, sa.2, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

13. REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

Yildirim T. D., Erpek E., Ulusoy B. O., Unaldi E., Cagdas O. S., Kardas R. C., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

14. LONG-TERM FOLLOW-UP AND RESULTS OF CHILDHOOD-ONSET ENTHESITIS-RELATED ARTHRITIS AND POLYARTHRITIS: HUR-BIO EXPERIENCE

Ata E. B., Kilic L., Bilgin E., Uzun G. S., Ayan G., Ekici M., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

15. REAL-LIFE DATA COMPARING THE LONG-TERM OUTCOME AND TREATMENT IN ADULT AND PEDIATRIC DADA2 PATIENTS: SINGLE CENTER EXPERIENCE OVER 10 YEARS

Ayan G., BAŞARAN H. Ö., BÖLEK E. Ç., FIRLATAN YAZGAN B., Bulat B., BATU AKAL E. D., et al.
ANNALS OF THE RHEUMATIC DISEASES , ss.1113-1114, 2024 (SCI-Expanded, Scopus) identifier

16. DIFFERENCES IN THE CHARACTERISTICS OF D2T/ NOND2T-RA PATIENTS AND FACTORS ASSOCIATED WITH D2T-RA AT B/TSDMARD START

Eken A., Ayan G., Ozsoy Z., Uzun G. S., Ekici M., Unaldi E., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

17. CENTRAL NERVOUS SYSTEM INVOLVEMENT OF ANCA-ASSOCIATED VASCULITIS IN A SINGLE CENTER - HUVAC EXPERIENCE

Ozen N. P. A., Bilgin E., Duran E., TOPÇUOĞLU M. A., Arsava E. M., Gocmen R., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

18. Prospective assessment of glucocorticoid toxicity in rheumatology practice: a focus on the glucocorticoid toxicity index

Bahap-Kara M., SARIYILDIZ E., ZENGİN H. Y., KARADAĞ Ö., EKİNCİOĞLU A.
RHEUMATOLOGY , sa.3, ss.1010-1018, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

19. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study

Culerrier J., Nguyen Y., KARADAĞ Ö., SÖZEN ŞAHNE B., Yildrim T. D., Ögüt T. S., et al.
Rheumatology (United Kingdom) , cilt.63, sa.4, ss.999-1006, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

20. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.

Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.
Clinical and experimental rheumatology , cilt.42, sa.4, ss.816-821, 2024 (SCI-Expanded, Scopus) identifier identifier

21. A close look at the nutritional status and mediterranean diet adherence in patients with behcet's syndrome

ERSOY N., BÖLEK E. Ç., Farisoǧullari B., Çinar N., Garipoǧlu G., Çolak S., et al.
Mediterranean Journal of Nutrition and Metabolism , cilt.17, sa.1, ss.43-52, 2024 (ESCI, Scopus) identifier identifier

22. Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study

Di Matteo A., Smerilli G., Di Donato S., Liu A. R., Becciolini A., Camarda F., et al.
Annals of the Rheumatic Diseases , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

23. Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study

Geraldes R., Santos M., Ponte C., Craven A., Barra L., Robson J. C., et al.
Journal of Neurology , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

24. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

25. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study

KARADAĞ Ö., BÖLEK E. Ç., AYAN G., Mohammad A. J., Grayson P. C., Pagnoux C., et al.
Arthritis and Rheumatology , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

26. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: Real life experience from the TReasure Registry

KARADAĞ Ö., Farisogullari B., YAĞIZ B., Erden A., Ademoglu Z., Kimyon G., et al.
Clinical and Experimental Rheumatology , cilt.42, sa.1, ss.130-137, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

27. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.

Can Bostan Ö., Duran E., Tuncay G., Cihanbeylerden M., Karadag Ö., Damadoglu E., et al.
The Journal of asthma : official journal of the Association for the Care of Asthma , cilt.60, sa.5, ss.931-937, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

28. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?

Duran E., Kilic L., Durhan G., Inkaya A. Ç., Guven G. S., Karakaya G., et al.
Annals of the rheumatic diseases , cilt.82, sa.4, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

29. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis.

Ponte C., Grayson P. C., Robson J. C., Suppiah R., Gribbons K. B., Judge A., et al.
Annals of the rheumatic diseases , cilt.81, sa.12, ss.1647-1653, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier

30. Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study

Di Matteo A., Cipolletta E., Castaniti G. M. D., Smerilli G., Airoldi C., Aydin S. Z., et al.
RHEUMATOLOGY , cilt.61, ss.4863-4874, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

31. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.

Grayson P. C., Ponte C., Suppiah R., Robson J. C., Gribbons K. B., Judge A., et al.
Annals of the rheumatic diseases , cilt.81, sa.12, ss.1654-1660, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier

32. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?

Farisogullari B., Cuceoglu M., Oral H., Yardimci G. K., Bilginer Y., Ozen S., et al.
Internal and emergency medicine , cilt.17, sa.6, ss.1599-1608, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

33. Recurrent Aphthous Stomatitis and Related Factors in Turkish Adult Population: A Striking Outcome of Cappadocia Chronic Diseases Epidemiological Study

ÇALIK BAŞARAN N., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., ERDEN A., KILIÇ L., et al.
Cumhuriyet Tıp Dergisi (ELEKTRONİK) , cilt.44, sa.3, ss.233-238, 2022 (Hakemli Dergi)

34. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis.

Grayson P. C., Ponte C., Suppiah R., Robson J. C., Craven A., Judge A., et al.
Annals of the rheumatic diseases , cilt.81, sa.3, ss.309-314, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier

35. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis.

Suppiah R., Robson J. C., Grayson P. C., Ponte C., Craven A., Khalid S., et al.
Annals of the rheumatic diseases , cilt.81, sa.3, ss.321-326, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier

36. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.

Robson J. C., Grayson P. C., Ponte C., Suppiah R., Craven A., Judge A., et al.
Annals of the rheumatic diseases , cilt.81, sa.3, ss.315-320, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier

37. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

Ytterberg S. R., Bhatt D. L., Mikuls T. R., Koch G. G., Fleischmann R., Rivas J. L., et al.
The New England journal of medicine , cilt.386, sa.4, ss.316-326, 2022 (SCI-Expanded, Scopus) identifier

38. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.

Farisoğulları B., Yardımcı G. K., Sarı A., Bilgin E., Bölek E. Ç., Duran E., et al.
Clinical and experimental rheumatology , cilt.40, sa.1, ss.112-119, 2022 (SCI-Expanded, Scopus) identifier identifier

39. Successful treatment of penile Mondor's disease with infliximab in a patient with Behçet's disease.

Özbek D. A., Bilgin E., Onur M. R., Karadağ Ö., Kiraz S.
Rheumatology (Oxford, England) , cilt.60, sa.11, 2021 (SCI-Expanded, Scopus) identifier

40. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis.

Lanzillotta M., Della-Torre E., Wallace Z. S., Stone J. H., Karadag Ö., Fernández-Codina A., et al.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] , cilt.21, sa.7, ss.1395-1401, 2021 (SCI-Expanded, Scopus) identifier

41. Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: is drug interaction the culprit?

DURAN E., BİLGİN E., BÖLEK E. Ç., FIRAT O., BULUT E. G., KALYONCU U., et al.
DRUG METABOLISM AND PERSONALIZED THERAPY , cilt.36, sa.2, ss.169-172, 2021 (Scopus) identifier identifier

42. Is Takayasu's arteritis more severe in children?

Bolek E., Kaya A., Sari A., Sag E., Demir S., Kilic L., et al.
Clinical and experimental rheumatology , sa.2, ss.32-38, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

43. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.

Monti S., Craven A., Klersy C., Montecucco C., Caporali R., Watts R., et al.
Rheumatology (Oxford, England) , cilt.60, sa.2, ss.617-628, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

44. Mediastinal mass in a patient with rheumatoid arthritis: lymphoid cystic thymic hyperplasia

ORAL H., BİLGİN E., YILDIRIM S., ÖNDER S. Ç., DEMİRKAZIK F., Serkan U., et al.
RHEUMATOLOGY ADVANCES IN PRACTICE , cilt.5, sa.2, 2021 (ESCI, Scopus) Creative Commons License identifier identifier identifier

45. Predictive factors for work-day loss in Behcet's syndrome: A multi-center study

MUMCU G., Yay M., Aksoy A., Tas M. N., ARMAĞAN B., SARI A., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

46. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2

Ozen S., Bilginer Y., Batu E., Taşkıran E., Özkara H. A., Ünal Ş., et al.
JOURNAL OF RHEUMATOLOGY , cilt.47, sa.1, ss.117-125, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

47. Two cases of glutaric aciduria type II: how to differentiate from inflammatory myopathies?

Koca M., Erden A., Armagan B., Sari A., Yildiz F., Ozdamar S., et al.
Acta clinica Belgica , cilt.74, sa.6, ss.451-455, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

48. Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritisanti-TNF

Duran E., Yildirim B. E. S., KARADAĞ Ö.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.5, sa.9, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

49. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behcet's syndrome: a multicentre study

Mumcu G., Karacayli U., Yay M., Aksoy A., Tas M. N., Armagan B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.98-104, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

50. Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis.

Ortiz-Fernández L., Carmona F. D., López-Mejías R., González-Escribano M. F., Lyons P. A., Morgan A. W., et al.
Annals of the rheumatic diseases , cilt.77, sa.4, ss.589-595, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

51. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.

Aydin S. Z., Direskeneli H., Merkel P. A., Ytterberg S., Blockmans D., Sato E. I., et al.
The Journal of rheumatology , cilt.44, sa.12, ss.1928-1932, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

52. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.

Carmona F. D., Coit P., Saruhan-Direskeneli G., Hernández-Rodríguez J., Cid M. C., Solans R., et al.
Scientific reports , cilt.7, ss.43953, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

53. Systemic involvements and preferred treatments in a large cohort of Behçet's disease.

Yilmaz S., Karadag Ö., Yazisiz V., Altun B., Gezer M., Karaman M., et al.
Rheumatology international , cilt.33, sa.12, ss.3025-30, 2013 (SCI-Expanded, Scopus) identifier identifier

54. The presence of MEFV gene mutations in patients with primary osteoarthritis who require surgery.

Yilmaz S., Erdem H., Tunay S., Torun D., Genc H., Tunca Y., et al.
The Korean journal of internal medicine , cilt.28, sa.5, ss.594-8, 2013 (Scopus) Creative Commons License identifier identifier

55. The factors considered as trigger for the attacks in patients with familial Mediterranean fever

Karadag Ö., TUFAN A., Yazisiz V., Ureten K., Yilmaz S., Cinar M., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.33, sa.4, ss.893-897, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

56. Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides.

Gok M., Erdem H., Gogus F., Yilmaz S., Karadag Ö., Simsek I., et al.
Rheumatology international , cilt.33, sa.4, ss.879-85, 2013 (SCI-Expanded, Scopus) identifier identifier

57. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis

KISACIK B., Tufan A., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., OZTURK M. A., et al.
JOINT BONE SPINE , cilt.75, sa.3, ss.291-294, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

58. Risk of cancer in Turkish patients after treatment with TNF antagonists.

Pay S., Oztürk M. A., Can G., Cefle A., Cobankara V., Erer B., et al.
Rheumatology (Oxford, England) , cilt.47, sa.4, ss.548-9, 2008 (SCI-Expanded, Scopus) identifier identifier

59. Accurate diagnosis of acute abdomen in FMF and acute appendicitis patients: how can we use procalcitonin?

Kisacik B., Kalyoncu U., Erol M. F., Karadag Ö., Yildiz M., Akdogan A., et al.
CLINICAL RHEUMATOLOGY , cilt.26, sa.12, ss.2059-2062, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

60. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever

Tufan A., Babaoglu M. O., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al.
JOURNAL OF RHEUMATOLOGY , cilt.34, sa.7, ss.1540-1544, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

61. Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis.

Onal I. K., Dağdelen S., Atmaca A., Karadağ Ö., Adalar N.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists , cilt.12, sa.3, ss.299-301, 2006 (Scopus) identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 142

1. IgG4-Related Pachymeningitis: How Do I Recognize?

ARSLAN D., Yardimci G., BABAOĞLU B., BÖLEK E. Ç., KILIÇ L., Saglam A., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.656, (Özet Bildiri) identifier

2. IMPACT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH AS USING BIOLOGIC AGENTS

Uzun G. S., YALÇIN ÇAKIR F., BİLGİN E., Farisogullari B., AYAN G., Ozsoy Z., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1695, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

3. IDENTIFICATION OF HISTOPATHOLOGIC FINDINGS OF PATIENTS WITH GIANT CELL ARTERITIS: A MULTICENTRE STUDY IN THE ERA OF 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GCA

Uzun G. S., Gokoz O., Heper A., Ogut B. C., Guresci S., Omma A., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1584-1585, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

4. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

Bolek E. C., AYAN G., BİLGİN E., Ediboglu E. D., Duran E., Kardas C., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1597-1598, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

5. FACTORS ASSOCIATED WITH PERSISTENTLY HIGH HAQ-DI SCORE IN RA PATIENTS UNDER B/ TSDMARDS: LONGITUDINAL ANALYSIS OF HURBIO SINGLE CENTER REGISTRY

BİLGİN E., GÜVEN E., FIRLATAN B., Ekici M., Bayram G. S. K., Unaldi E., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.500, (Özet Bildiri) Creative Commons License identifier

6. EVALUATION OF THE EFFECT OF TUMOR NECROSIS FACTOR - A THERAPY ON 24-HOUR AMBULATORY BLOOD PRESSURE MEASUREMENT AND SLEEP QUALITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

Moral K., BİLGİN E., KARADAĞ Ö., Kalyoncu U., Akdogan A., Bilgen S. A., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1689, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

7. Antiretroviral therapy causes a reduction in T-cell exhaustion, which is preserved after switching to a new therapy regimen

Özcan B., Tavukçuoğlu E., KARA E., Horzum U., AYAN G., SÖNMEZER M. Ç., et al.
18th European AIDS Conference (EACS 2021), London, Kanada, 27 Ekim 2021, cilt.1, ss.52-53, (Tam Metin Bildiri)

8. ROMATOİD ARTRİTLİ BİR HASTADA MEDİASTİNAL KİTLE: LENFOİD KİSTİK TİMİK HİPERPLAZİ

ORAL H., BİLGİN E., YILDIRIM S., ÖNDER S. Ç., DEMİRKAZIK F., UYSAL S., et al.
14. Anadolu Romatoloji Günleri, Online Kongre, 26 - 30 Mayıs 2021, (Özet Bildiri)

9. CONCOMITANT PSORIATIC ARTHRITIS AND INFLAMMATORY BOWEL DISEASE IN THE PSA BIOLOGICAL REGISTRY: HUR-BIO REAL LIFE RESULTS

Yardimci G. K., Farisogullari B., Armagan B., Bilgin E., Bolek E. C., Duran E., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1174-1175, (Özet Bildiri) identifier

10. SUBPHENOTYPES IN POLYARTERITIS NODOSA (PAN): TARGET ORGAN ASSOCIATIONS OF A WORLDWIDE COLLABORATION STUDY

Karadag O., Bolek E. C., Furuta S., Emmi G., Hocevar A., Hinojosa-Azaola A., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1060-1061, (Özet Bildiri) identifier

11. BIOSIMILAR INFLIXIMAB EXPERIENCE IN SPONDYLOARTRITIS PATIENTS: TREASURE REAL LIFE RESULTS

Bilge N. S. Y., Kasifoglu T., Kiraz S., Ertenli A. I., Dalkilic E., Bes C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1616, (Özet Bildiri) Creative Commons License identifier

12. SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS

Armagan B., Kilic L., Yardimci G. K., Bilgin E., Farisogullari B., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.419-420, (Özet Bildiri) Creative Commons License identifier

13. LOCALISATION OF RHEUMATOID LUNG NODULES IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE: RIGHT OR LEFT?

Bilgin E., Ekici M., Baytar Y., Duran E., Durhan G., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.277, (Özet Bildiri) identifier

14. EMERGING AUTOANTIBODIES PANEL (MYOSITIS ASSOCIATED AND MYOSITIS SPECIFIC ANTIBODIES) IN INFLAMMATORY MYOPATHIES: THE FREQUENCIES OF AND RELATIONSHIP WITH CLINICAL FEATURES

Yardimci G. K., Erul E., Bilgin E., Farisogullari B., Kilic L., Saribas Z., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1605-1606, (Özet Bildiri) Creative Commons License identifier

15. CONCOMITANT USE OF BIOLOGIC DMARDS WITH CSDMARDS INCREASES DRUG RETENTION RATE AND IMPROVES TREATMENT RESPONSE IN THE PSORIATIC ARTHRITIS. HUR-BIO REAL LIFE RESULTS

Duran E., Bilgin E., Bolek E. C., Yardimci G. K., Farisogullari B., Kilic L., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.757, (Özet Bildiri) Creative Commons License identifier

16. CONVENTIONAL SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS - CHANGING PRACTICE IN BIOLOGIC ERA: REAL-LIFE RESULTS FROM HURBIO-PSA REGISTRY

Bilgin E., Duran E., Bolek E. C., Farisogullari B., Yardimci G. K., Kilic L., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1663, (Özet Bildiri) Creative Commons License identifier

17. EFFICACY, RETENTION RATE AND PREDICTORS OF TOFACITINIB EFFICACY AND RETENTION IN RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL-LIFE EXPERIENCE

Bilgin E., Ceylan F., Bolek E. C., Duran E., Farisogullari B., Yardimci G. K., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1460, (Özet Bildiri) Creative Commons License identifier

18. PREDICTORS AND SEVERITY OF POST-THROMBOTIC SYNDROME IN VASCULAR BEHCET'S DISEASE: RETROSPECTIVE MULTICENTER STUDY

Aksoy A., Colak S., Yagiz B., Seniz B. N., Omma A., Yildiz Y., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.367-368, (Özet Bildiri) identifier

19. FACTORS RELATED TO RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

Kalyoncu U., Ekici M., Bilgin E., Sari A., Baytar Y., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1394, (Özet Bildiri) Creative Commons License identifier

20. THE INFLUENCE OF OBESITY ON BIOLOGICAL DMARD TREATMENT RESPONSE IN PSORIATIC ARTHRITIS: HUR-BIO REAL LIFE RESULTS

Farisogullari B., Yardimci G. K., Bolek E. C., Bilgin E., Duran E., Ayan G., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1675-1676, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

21. INFLAMMATORY ORBITAL DISEASES: THE EXPERIENCE OF A TERTIARY RHEUMATOLOGY CENTRE

Aksun M. S., Sahin T. K., Bolek E. C., Kilic L., Bulut E. G., Oguz K. K., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1806-1807, (Özet Bildiri) identifier

22. CANCER INCIDENCE AND FEATURES IN ADULT VASCULITIS PATIENTS

Kardas R. C., Bolek E. C., Aktas B. Y., Kilickap S., Karadag O.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.682-683, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

23. INCIDENCE RATE OF HERPES ZOSTER IN RHEUMATOID ARTHRITIS PATIENTS UNDER TOFACITINIB: REAL-LIFE DATA FROM TURKEY - HURBIO REGISTRY

Bilgin E., Ceylan F., Duran E., Bolek E. C., Farisogullari B., Yardimci G. K., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.636, (Özet Bildiri) Creative Commons License identifier

24. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results

FARİSOĞULLARI B., YARDIMCI G. K., SARI A., ARMAĞAN B., BİLGİN E., BÖLEK E. Ç., et al.
2019 ACR/ARP Annual Meeting, 8 - 13 Kasım 2019, (Özet Bildiri)

25. Amyloidosis in Behcet’s Disease: Experience of a Vasculitis Centre at Silk Road

BÖLEK E. Ç., ERUL M. E., YARDIMCI G. K., KILIÇ L., AKDOĞAN A., KARADAĞ Ö.
2019 ACR/ARP Annual Meeting, ATLANTA, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)

26. Retention Rates and Response of Anti-TNF Treatments in the Enteropathic Spondylitis: HUR-BIO Real Life Results

YARDIMCI G. K., FARİSOĞULLARI B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.
2019 ACR/ARP Annual Meeting, ATLANTA, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)

27. Behçet Hastalığı’nda Hastaların Akdeniz Diyeti Uyumlarının Değerlendirilmesi veAntropometrik Ölçümlerine İncelenmesi: Kesitsel Pilot Çalışma

ERSOY N., BÖLEK E. Ç., Farisoğulları B., BİLGİN E., GARİPOĞLU G., KILIÇ L., et al.
20. Ulusal RomatolojiKongresi, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)

28. Alt ekstremite ağrılarının nadir bir sebebi:Erdheim-Chester hastalığı

DOĞAN Y., BÖLEK E. Ç., KARADAĞ Ö., AKINCI A.
20.ulusal romatoloji kongresi, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.135, (Tam Metin Bildiri)

29. Psöriatik artrit hastalar›nda 5 yıllık anti-TNF alfa kullanımı sonrasında subklinik aterosklerozun değişimi

ERDEN A., CANPOLAT U., UYAROĞLU O. A., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.
XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.233-234, (Özet Bildiri)

30. SAT0372 CHANGE OF SUBCLINICAL ATHEROSCLEROSIS AFTER FIVE YEARS ANTI-TNF TREATMENTS IN PSORIATIC ARTHRITIS

ERDEN A., CANPOLAT U., UYAROĞLU O., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 Haziran - 15 Aralık 2019, cilt.78, ss.1269, (Özet Bildiri) Creative Commons License identifier

31. AB0574 A MONOGENIC DISEASE WITH WIDE RANGE OF SYMPTOMS: DEFICIENCY OF ADENOSINE DEAMINASE 2

BATU AKAL E. D., TAŞKIRAN Z. E., TEZCAN F. İ., ÖZKARA H. A., ÇAĞDAŞ AYVAZ D. N., ÖZEN S., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1748, (Tam Metin Bildiri) Creative Commons License identifier

32. ENTEROPATHIC ARTHRITIS PATIENTS UNDER BDMARD TREATMENTS HAD FREQUENTLY RADIOGRAPHIC SACROILIITIS: HUR-BIO REAL LIFE RESULTS

YARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.478, (Özet Bildiri) Creative Commons License identifier

33. IS THERE AN OVERLAP OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES WITH IGG4-RELATED DISEASE OR NOT?

ERDEN A., BÖLEK E. Ç., YARDIMCI G. K., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.990, (Özet Bildiri) Creative Commons License identifier

34. OFF-LABEL USE OF BIOLOGICAL THERAPIES IN RELAPSING AND/OR REFRACTORY POLYARTERITIS NODOSA

Canzian A., KARADAĞ Ö., Contis A., Maurier F., Sartorelli S., Denis L., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1186-1187, (Özet Bildiri) Creative Commons License identifier

35. CLINICAL FEATURES OF ANEURYSMAL BEHCET DISEASE

ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1182, (Özet Bildiri) Creative Commons License identifier

36. UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITIS

Bilge N. S. Y., KAŞİFOĞLU T., KİRAZ S., ERTENLİ A. İ., Kucuksahin O., Dalkilic E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.491, (Özet Bildiri) Creative Commons License identifier

37. ANEURYSM IN BEHCET'S DISEASE: MANAGEMENT, PROGNOSIS AND MORTALITY

ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.422, (Özet Bildiri) Creative Commons License identifier

38. VALIDATION OF A NOVEL DISEASE CLASSIFICATION IN HACETTEPE TAKAYASU ARTERITIS COHORT

BÖLEK E. Ç., DEMİR S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1192, (Özet Bildiri) Creative Commons License identifier

39. COMPARISON OF SURVIVAL RATES AMONG SUBGROUPS OF PATIENTS EVALUATED FOR FEVER OF UNKNOWN ORIGIN

BİLGİN E., ARMAĞAN B., SARI A., BÖLEK E. Ç., Farisogullari B., YARDIMCI G. K., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.573, (Özet Bildiri) Creative Commons License identifier

40. SMOKING MAY BE RELATED TO SACROILIITIS IN ENTEROPATHIC ARTHRITIS PATIENTS: TREASURE REAL-LIFE PRELIMINARY DATA

Kucuksahin O., ERDEN A., Ilgen U., KİRAZ S., ERTENLİ A. İ., Bilge N. S. Y., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1824-1825, (Özet Bildiri) Creative Commons License identifier

41. VALIDATION OF THE GIANT CELL ARTERITIS CLASSIFICATION CRITERIA IN TURKISH PATIENTS

ARMAĞAN B., YILDIRIM A., Onur M., Yardimci G., KILIÇ L., KALYONCU U., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri) identifier

42. VALIDITY OF ACR/EULAR 2017 PROVISIONAL CLASSIFICATION CRITERIA FOR ANCA-ASSOCIATED VASCULITIS IN TURKISH PATIENTS AND COMPARISON WITH 1990 CRITERIA

Yardimci G., BİLGİN E., ARMAĞAN B., Farisogullari B., KILIÇ L., AKDOĞAN A., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.39, (Özet Bildiri) identifier

43. ASSESSMENT OF DAMAGE AND PROGNOSIS IN PATIENTS WITH ADULT IGA VASCULITIS: A RETROSPECTIVE MULTICENTERED COHORT STUDY

Gazel U., Omma A., SARI A., Cansu D. U., YAZICI A., Cefle A. E., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri) identifier

44. CEREBROVASCULAR EVENT CAN BE THE PRESENTING FEATURE OF TAKAYASU ARTERITIS: RESULTS OF A PROSPECTIVE VASCULITIS CENTER

SARI A., BÖLEK E. Ç., KILIÇ L., ARSAVA E. M., TOPÇUOĞLU M. A., KALYONCU U., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri) identifier

45. ARE CHILDHOOD-ONSET AND ADULT-ONSET TAKAYASU ARTERITIS SIMILAR IN TERMS OF CLINICAL FEATURES AND DISEASE COURSE?

Cagri E., Demir B. S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.63, (Özet Bildiri) identifier

46. PEDIATRIC TO ADULT RHEUMATOLOGY CARE TRANSITION PROGRAMME OF HACETTEPE UNIVERSITY: VASCULITIDES PERSPECTIVE

BÖLEK E. Ç., DEMİR S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri) identifier

47. SECONDARY VASCULITIS DUE TO SINGLE GENE DEFECTS

ÖZEN S., BİLGİNER Y., Batu E., KARADAĞ Ö., ALİKAŞİFOĞLU M.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri) identifier

48. Anevrizması olan Behçet hastalar›n tedavisi, prognozu ve mortalitesi

Armagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.
XIX. Ulusal Romatoloji Kongresi2, Türkiye, 26 - 30 Ekim 2018, (Özet Bildiri)

49. Evaluation of patients with the diagnosis of vasculitis admitted to a medical ICU

ORTAÇ ERSOY N. E., ÖZEN S., ER B., ÖCAL S., ERDEN A., YARDIMCI G. K., et al.
LIVES, 2018, 20 - 24 Ekim 2018, (Özet Bildiri)

50. The Existence Of Exosomal MiRNAs In The Circulation In Familial Mediterranean Fever (FMF) Patients

tavukcuoglu z., AKKAYA ULUM Z. Y., YERSAL N., AKBABA T. H., yardimci g. k., karadag o., et al.
EBML Symposia, 3 - 06 Ekim 2018, (Özet Bildiri)

51. Spinal Cord Involvement in Behcet’xxs Disease-Experience of a Vasculitis Centre at Silk Road

BÖLEK E. Ç., SARI A., KILIÇ L., AKDOĞAN A., TUNCER M. A., KARADAĞ Ö.
ACR 2018, 20 - 24 Ekim 2018, cilt.70, ss.1806, (Tam Metin Bildiri)

52. Arteriyel anevrizması olan Behçet hastalarnın klinik özellikleri

Armagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.
XIX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.68-69, (Özet Bildiri)

53. FREQUENCY OF PULMONARY HYPERTENSION IN BEHCET'S DISEASE

Armagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1471, (Özet Bildiri) Creative Commons License identifier

54. ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS

Kilic L., Karadag O., Erden A., Sari A., Armagan B., Firat E., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.437-438, (Özet Bildiri) Creative Commons License identifier

55. IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY

Alibaz-Oner F., Balci M. A., Pamuk O. N., Zengin O., Tasci M., Dogru A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1118-1119, (Özet Bildiri) Creative Commons License identifier

56. IDIOPATHIC GRANULOMATOUS MASTITIS MAY RESPONSE WELL TO COMBINATION OF IMMUNOSUPRESIVES AND GLUCOCORTICOIDS

Sari A., Konan A., Akpinar M., Armagan B., Erden A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1152-1153, (Özet Bildiri) Creative Commons License identifier

57. WHICH ONE IS MORE VALUABLE FOR DIAGNOSIS OF ADULT ONSET STILL'S DISEASE? SOLELY NEUTROPHILIA OR LEUKOCYTOSIS WITH NEUTROPHILIA?

Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1150, (Özet Bildiri) Creative Commons License identifier

58. HOW TO DIFFERENTIATE ADULT ONSET STILL'S DISEASE FROM OVERALL OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY FROM A TERTIARY REFERRAL CENTRE

BİLGİN E., Erden A., Armagan B., KILIÇ L., Sari A., YARDIMCI G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1156-1157, (Özet Bildiri) Creative Commons License identifier

59. RETENTION RATES OF CERTOLIZUMAB PEGOL IN ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS

Armagan B., Sari A., Erden A., Yardimci G. K., Kilic L., Kalyoncu U., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1001-1002, (Özet Bildiri) Creative Commons License identifier

60. FOUR YEARS OF DELAY IN THE DIAGNOSIS OF SAPHO SYNDROME: SINGLE TERTIARY CENTRE EXPERIENCE

Erden A., Ekici M., Armagan B., Sari A., Yardimci G. K., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1552, (Özet Bildiri) Creative Commons License identifier

61. ASSESSMENT OF DAMAGE AND PROGNOSIS IN PATIENTS WITH ADULT IGA VASCULITIS: RETROSPECTIVE MULTICENTERED COHORT STUDY

Alibaz-Oner F., Omma A., Sari A., Gazel U., Cansu D. U., YAZICI A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1474-1475, (Özet Bildiri) Creative Commons License identifier

62. PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY

Kalvoncu U., Kiraz S., Bilgen S. A., Karadag O., Akdogan A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1601-1602, (Özet Bildiri) Creative Commons License identifier

63. COMPARISON OF CUT-OFF VALUES FOR FERRITIN TO DISCRIMINATE ADULT ONSET STILL'S DISEASE FROM OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY

Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1675, (Özet Bildiri) Creative Commons License identifier

64. POLYARTERITIS NODOSA: OVER 20 YEARS' CLINICAL EXPERIENCE

Sonmez H. E., Armagan B., Ayan G., BARUT K., Batu E. D., Erden A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.775-776, (Özet Bildiri) Creative Commons License identifier

65. ANKİLOZAN SPONDİLİTTE EKLEM MOBİLİTESİNİN BİREYLERİN SAĞLIK ALGISINA ETKİSİNİN İNCELENMESİ

ARIN G., TÜRKMEN N. B., OFLAZ F. B., ERDEN A., KARADAĞ Ö., GÖKSÜLÜK D., et al.
3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, (Özet Bildiri)

66. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?

ERDEN A., BATU E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., FIRAT E., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

67. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts

KARADAĞ Ö., ERDEN A., BİLGİNER Y., GOPALUNI S., SARI A., ARMAĞAN B., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

68. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results

ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

69. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life Experiences

UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

70. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

71. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis

SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

72. Sjögren Sendromu’nun Kas Güçsüzlüğü ile Prezantasyonu: Renal Tubuler Asidoz Tip 1

BÖLEK E. Ç., ERDEN A., KOÇ H., KARADAĞ Ö., KALYONCU U., KİRAZ S., et al.
19.Ulusal İç Hastalıkları Kongresi, Türkiye, 11 - 15 Ekim 2017, (Tam Metin Bildiri)

73. Distribution of vasculitides in Eastern mediteranean: Results of a prospective cohort

KARADAĞ Ö., ERDEN A., BATU E. D., BİLGİN E., UYAROGLU o., ŞEYHOĞLU E., et al.
EUROPEAN LEAGUE AGAİNST RHEUMATOLOGY ANNUAL MEETİNG 2017, 14 - 17 Haziran 2017, (Tam Metin Bildiri)

74. A Section of Rare Diseases in Hacettepe Adult Clinics in Rheumatology: Deficiency of Adenosine Deaminase 2 (DADA2)

BÖLEK E. Ç., ERDEN A., ÖZEN S., KARADAĞ Ö., KALYONCU U., BATU E. D., et al.
5th Rare Diseases Summer School, 7 - 09 Haziran 2017, (Tam Metin Bildiri)

75. PREMATURE CORONARY HEART DISEASE FREQUENCY IN RHEUMATOID ARTHRITIS WHO ARE RECEIVING BIOLOGIC AGENTS: HUR-BIO REAL LIFE RESULTS

Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.250-251, (Özet Bildiri) Creative Commons License identifier

76. ADHERENCE OF RHEUMATIC PATIENTS TO INH PROPHYLAXIS PRESCRIBED BEFORE BIOLOGICAL TREATMENT: HUR-BIO SINGLE CENTER REAL LIFE RESULTS

Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1035, (Özet Bildiri) Creative Commons License identifier

77. PSORIASIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

Erden A., Batu E. D., Bilgin E., Sonmez H. E., Seyhoglu E., Demir S., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.414, (Özet Bildiri) identifier

78. THORAX CT FINDINGS IN A LARGE COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS

Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.256, (Özet Bildiri) Creative Commons License identifier

79. ABATACEPT EXPERIENCE IN BIOLOGIC NAIVE RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS

Sari A., Armagan B., Kilic L., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.854-855, (Özet Bildiri) Creative Commons License identifier

80. DISTRIBUTION OF VASCULITIDES IN EASTERN MEDITERRANEAN: RESULTS OF A PROSPECTIVE COHORT

Karadag O., Erden A., Batu E. D., Bilgin E., Uyaroglu A. O., Seyhoglu E., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.616, (Özet Bildiri) Creative Commons License identifier

81. . IGG4-RELATED DISEASE IN EASTERN MEDITERRANEAN: CLINICAL FEATURES AND OUTCOMES OF A LARGE COHORT

KARADAĞ Ö., ERDEN A., AYHAN E. A., BÖLEK E. Ç., ARMAĞAN B., KILIÇ L., et al.
EULAR 2017, 6 - 10 Haziran 2017, cilt.76, ss.720, (Özet Bildiri) Creative Commons License identifier

82. THERE IS A COMMUNICATION PROBLEM BETWEEN PATIENT AND PHYSICIAN DURING PRE-CONCEPTIONAL PERIOD: HUR-BIO REAL LIFE RESULTS

Uyaroglu O. A., Seyhoglu E., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.448, (Özet Bildiri) Creative Commons License identifier

83. ANKYLOSING SPONDYLITIS PATIENTS WITH UVEITIS HAD BETTER ADALIMUMAB RETENTION RATE: HUR-BIO REAL LIFE RESULTS

Armagan B., Sari A., Erden A., Kilic L., Guven D. C., Pashayev T., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1300-1301, (Özet Bildiri) Creative Commons License identifier

84. RAID COMPOSITE INDEX IN THE EVALUATION OF RA PATIENTS RECEIVING BIOLOGICAL TREATMENT: HUR-BIO REAL-LIFE RESULTS

Erden A., Kilic L., Armagan B., Sari A., Akdogan A., Bilgen S. A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1113, (Özet Bildiri) Creative Commons License identifier

85. COMORBIDITY AND SURGERY HISTORY OF RHEUMATOID ARTHRITIS PATIENTS WHO ARE RECEIVING BIOLOGICAL AGENT

Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.534, (Özet Bildiri) Creative Commons License identifier

86. WIDE HETEROGENEITY IN TREATMENT PROTOCOLS AND INAPPROPIATE USE OF PREDNISOLONE FOR ANTI-RO/LA ASSOCIATED-CONGENITAL HEART BLOCK: A SYSTEMATIC REVIEW OF 492 CASES

Erden A., Kilic L., Bilgin E., Fanouriakis A., Ceylan S., Hyrnabaccus B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1215-1216, (Özet Bildiri) Creative Commons License identifier

87. THERAPEUTIC PLASMA EXCHANGE (TPE) FOR REFRACTORY SLE: A COMPARISON OF OUTCOMES BETWEEN DIFFERENT SUB-PHENOTYPES?

Soyuoz A., Karadag O., Kilic L., Akyol T. K., Bilgen S. A., Ozcebe O. I.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1212, (Özet Bildiri) Creative Commons License identifier

88. FUNCTIONAL DISABILITY IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS

Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1127, (Özet Bildiri) Creative Commons License identifier

89. ARE THE DEMOGRAPHIC AND CLINICAL FEATURES OF POLYARTERITIS NODOSA SIMILAR BETWEEN THE UK AND TURKEY?

Karadag O., Erden A., Batu E. D., Gopaluni S., Sari A., Armagan B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.329, (Özet Bildiri) Creative Commons License identifier

90. THE USE OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: IN WHICH INFUSION INTERVALS WERE GIVEN AND HOW DID THEY RESPOND? HUR-BIO REAL LIFE RESULTS

Armagan B., Sari A., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1194-1195, (Özet Bildiri) Creative Commons License identifier

91. QUANTIFERON (R)-TB GOLD IN-TUBE ASSAY CAN BE USED FOR LATENT TUBERCULOSIS SCREENING BEFORE BIOLOGICAL DRUG TREATMENT IN A BCG VACCINATED COUNTRY: HUR-BIO SINGLE CENTER REAL LIFE RESULTS

Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1412-1413, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

92. PRESENTATION OF A NEW SCALE ASSESSING THE BIOPSYCHOSOCIAL ASPECTS OF HEALING PROPERTIES IN RHEUMATIC PATIENTS

ÜNAL E., KISACIK P., Arin G., KARABULUT E., GÖKSÜLÜK D., Yagli N. V., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1531, (Özet Bildiri) Creative Commons License identifier

93. IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY

Akar S., Cinar M., Sargin G., Karadag O., Kinikli G., Ozmen M., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.354, (Özet Bildiri) Creative Commons License identifier

94. BIOLOGICAL THERAPY IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS FOLLOWED IN ADULT RHEUMATOLOGY DEPARTMENT: HUR-BIO REAL LIFE RESULTS

Kilic L., Sari A., Armagan B., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.402, (Özet Bildiri) Creative Commons License identifier

95. Comorbidity and Surgery History of Rheumatoid Arthritis Patients Who Receiving Biological Agent

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
MIRCIM 2017 TIHUD-TIP JOINT MEETING, Krakow, Polonya, 11 - 14 Mayıs 2017, (Özet Bildiri)

96. SCALP NECROSIS IN NEUROFIBROMATOSIS TYPE-1 VASCULOPATHY: A DIAGNOSTIC DILEMMA

Guven D., SARI A., ARMAĞAN B., KİRAZ S., KILIÇ L., KARADAĞ Ö., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.101-102, (Özet Bildiri) identifier

97. ASSESSMENT OF PROGNOSIS AND DAMAGE IN PATIENTS WITH ADULT HENOCH SCHONLEIN PURPURA RETROSPECTIVE MULTICENTERED COHORT STUDY

ALİBAZ ÖNER F., ALİBAZ ÖNER F., Omma A., SARI A., KARADAĞ Ö., Cansu D. U., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.85-86, (Özet Bildiri) identifier

98. TWO-YEAR RESULTS OF A PROSPECTIVE VASCULITIS COHORT FROM EASTERN MEDITERRANEAN: DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES

KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., ARMAĞAN B., SARI A., ERDEN A., BATU AKAL E. D., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, (Özet Bildiri) identifier

99. LEUKOCYTOCLASTIC VASCULITIS IN THE BONE MARROW

SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., Ayhan A. S., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.72, (Özet Bildiri) identifier

100. EVALUATION OF ASSSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES OR LUPUS ANTICOAGULANT POSITIVITY AND SEVERITY OF VASCULAR INVOLVEMENT IN TAKAYASU ARTERITIS PATIENTS

FIRAT E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.48, (Özet Bildiri) identifier

101. SUCCESSFUL TREATMENT OF AORTOENTERIC FISTULA A PATIENT WITH BEHCET DISEASE INTERFERON ALFA2A AND SURGERY

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KALYONCU U., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri) identifier

102. OPHTALMOLOGIC FINDINGS IN PATIENTS WITH TAKAYASU'S ARTERITIS

Kelesoglu A. B., Baytaroglu A., Sari A., Erden A., Kilic L., Tatar O., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, ss.1101-1102, (Özet Bildiri) identifier

103. COMPARING THE CHARACTERISTICS OF ADULT AND PEDIATRIC PATIENTS WITH POLYARTERITIS NODOSA

Erden A., Batu E. D., Bilgin E., Sonmez H. E., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.799, (Özet Bildiri) identifier

104. DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES: A REAL-LIFE EXPERIENCE OF VASCULITIS CENTER FROM EASTERN MEDITERRANEAN

Karadag O., Erden A., Bilgin E., Batu E. D., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1096-1097, (Özet Bildiri) identifier

105. COMMON AND UNCOMMON MANIFESTATIONS OF GRANULOMATOSIS WITH POLIANGIITIS (GPA) AT CHEST CT: A VASCULITIS CENTER EXPERIENCE

Taydas O., Kilic L., Atceken Z., Erden A., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.796, (Özet Bildiri) identifier

106. DEMOGRAPHIC, CLINIC AND LABORATORY FEATURES OF 755 PATIENTS WITH NEONATAL LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW

Erden A., Kilic L., Bilgin E., Ceylan S., Hymabaccus B., Sener Y. Z., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.874, (Özet Bildiri) identifier

107. DAPSA WITH TWENTY-EIGHT JOINT COUNTS MAY BE USEFUL FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS

Kalyoncu U., Erden A., Kilic L., Sari A., Armagan B., Karadag O., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1159-1160, (Özet Bildiri) identifier

108. RITUXIMAB SEEMS OUTSTANDING BIOLOGICAL OPTION IN LATE ONSET RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS

Kilic L., Erden A., Sari A., Armagan B., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1022-1023, (Özet Bildiri) identifier

109. THE RHEUMATOLOGIST'S PERSPECTIVE IN DIAGNOSTIC COURSE AND MANAGEMENT OF FAMILIAL MEDITERRANEAN FEVER

Karadag O., Kilic L., Erden A., Kasifoglu T., Karaaslan Y., Kiraz S., et al.
18th ISPOR Annual European Congress, Milan, İtalya, 7 - 11 Kasım 2015, cilt.18, (Özet Bildiri) Creative Commons License identifier

110. Comorbidities in patients with Familial Mediterranean Fever

B Balci P., ARICI Z. S., Avcı E., BATU E. D., Arslanoğlu E., Burak Ç., et al.
8th International congressof familial mediterranean fever and systemic autoinflammatory diseases, 30 Eylül - 03 Ekim 2015

111. Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide

Yilmaz N., Emmungil H., Gucenmez S., Ozen G., Yildiz F., Balkarli A., et al.
11th International Congress on Systemic Lupus Erythematosus, Vienna, Avusturya, 2 - 06 Eylül 2015, cilt.33, (Özet Bildiri) identifier

112. INCREASED EPICARDIAL ADIPOSE TISSUE IN PATIENTS WITH SYSTEMIC SCLEROSIS

Yilmaz N., Baysal E., Karadag O.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.563, (Özet Bildiri) identifier

113. RETROPERITONEAL FIBROSIS, IGG4-RELATED DISEASES AND CARDIOVASCULAR FIBROSCLEROSIS

Karadag O., Kalyoncu U., Kilic L., Helvaci O., Sener Y. Z., Akdogan A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.1108-1109, (Özet Bildiri) identifier

114. RETRO-ORBITAL GRANULOMA IN GRANULOMATOSIS WITH POLYANGIITIS

Bitik B., Kilic L., Kucuksahin O., Sahin K., Mercan R., Tufan A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.550, (Özet Bildiri) identifier

115. THE COMPARATIVE ONE-YEAR DRUG SURVIVAL RATE OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY

Sari I., Kalyoncu U., Onat A. M., Pamuk O. N., Karadag O., Kisacik B., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.425, (Özet Bildiri) identifier

116. FREQUENCY OF RADIOLOGICAL HIP INVOLVEMENT AND TOTAL HIP REPLACEMENT IN A LARGE SINGLE CENTER SPONDYLOARTHRITIS COHORT WITH BIOLOGICAL TREATMENTS: HUR-BIO REAL LIFE RESULTS

Kalyoncu U., Karadag O., Kilic L., Ertenli I., Bilgen S. A., Akdogan A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.726, (Özet Bildiri) identifier

117. EVALUATION OF SYSTEMIC SCLEROSIS PATIENTS BY QUANTITATIVE SENSORY TESTING FOR THE PRESENCE OF NEUROPATHY

Kilic L., Akdogan A., Karadag O., Kalyoncu U., Bilgen S. A., Ertenli I., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.660, (Özet Bildiri) identifier

118. THE PATIENT-DERIVED PSA IMPACT OF DISEASE (PSAID) QUESTIONNAIRE CORRELATES WITH OTHER OUTCOME MEASURES: HUR-BIO REAL LIFE RESULTS

Kilic L., Karadag O., Gossec L., Bilgen S. A., Akdogan A., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.739, (Özet Bildiri) identifier

119. SHORT TERM EFFICACY OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY

Cetin P., Kalyoncu U., Solmaz D., Sari I., Karadag O., Kilic L., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.724, (Özet Bildiri) identifier

120. PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS HAD SIMILAR TNFI DRUG SURVIVAL: HUR-BIO REAL LIFE RESULTS

Kalyoncu U., Karadag O., Kilic L., Bilgen S. A., Akdogan A., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.718, (Özet Bildiri) identifier

121. THERAPEUTIC PLASMA EXCHANGE (TPE) FOR REFRACTORY AUTOIMMUNE DISEASES: REPORT OF 60 CASES

Karadag O., Soyuoz A., Kalyoncu U., Karaagac T., Kilic L., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.528-529, (Özet Bildiri) identifier

122. PATIENTS WITH PSORIATIC ARTHRITIS HAD BETTER TNFI SURVIVAL THAN ANKYLOSING SPONDYLITIS: HUR-BIO REAL LIFE RESULTS

Kalyoncu U., Karadag O., Kilic L., Bilgen S. A., Akdogan A., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.744, (Özet Bildiri) identifier

123. RETENTION RATE OF TNF BLOCKERS IS GREATER IN CASE OF ADVANCED SPINAL ANKYLOSIS IN AXIAL SPONDYLOARTHRITIS: DATA FROM THE HUR-BIO REGISTRY

Kalyoncu U., Kilic L., Karadag O., Bilgen S. A., Akdogan A., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.727, (Özet Bildiri) identifier

124. RISK FACTORS OF ADVANCED SPINAL DISEASE AND/OR BAMBOO DISEASE IN PATIENTS WITH ANKYLOSING SPONYLITIS DURING TNFI TREATMENTS: HUR-BIO REAL LIFE RESULTS

Kalyoncu U., Karadag O., Kilic L., Ertenli I., Bilgen S. A., Akdogan A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.213, (Özet Bildiri) identifier

125. FAMILY HISTORY IN TURKISH ANKYLOSING SPONDYLITIS PATIENTS RECEIVING ANTI-TNF THERAPY

Kalyoncu U., Cetin P., Karadag O., Sari I., Kilic L., Ertenli I., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.435-436, (Özet Bildiri) identifier

126. Quantiferon-TB Test Can Be Usefull For Decision Of Anti-Tuberculosis Prophylaxis During Anti-TNF Treatment: Result Of Real Life

KALYONCU U., KILIÇ L., İNKAYA A. Ç., KARADAĞ Ö., Bilgen S. A., AKDOĞAN A., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

127. AB0589 SUBCLINICAL ATHEROSCLEROSIS FOUND BOTH IN PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS

APRAŞ BİLGEN Ş. Ş., KALYONCU U., KILIÇ L., KARADAĞ Ö., CANPOLAT U., AYTEMİR K., et al.
European League Against Rheumatism (EULAR) Congress, 12-15 June, 2013; Madrid-Spain., 12 - 15 Haziran 2013

128. AB0430 WHAT IS THE ROLE OF AMBULATORY BLOOD PRESSURE MONITORING IN SLE

ER E., AKDOĞAN A., KILIÇ L., CANPOLAT U., KAYA E. B., KARADAĞ Ö., et al.
European League Against Rheumatism (EULAR) Congress, 12-15 June, 2013; Madrid-Spain., 12 - 15 Haziran 2013

129. CROSS-Sectional Assessment of Damage in Takayasu Arteritis with A Validated Tool.

Omma A., Erer B., KARADAĞ Ö., Yilmaz N., ALİBAZ ÖNER F., Yildiz F., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri) identifier

130. THE RATE AND CAUSES OF SWITCHING AMONG THE RHEUMATIC PATIENTS UNDER BIOLOGIC THERAPY: FINDINGS FROM TURKISH RHEUMATOLOGY DATABASE-ROMADIGITAL

Karadag O., Yilmaz S., Kisacik B., KALYONCU U., Tezcan E., YILMAZ S., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri) identifier

131. MEFV mutations frequency and effect on disease severity in ankyloing spondylitis

Maras Y., Calguneri M., Akdogan A., Karadag O., Kalyoncu U., Ovunc B., et al.
Annual European Congress of Rheumatology (EULAR 2007), Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.400, (Özet Bildiri) identifier

132. Ankylosing spondylitis has a more severe disease course when coexist with Familial Mediterranean Fever.

Calguneri M., Kalyoncu U., Akdogan A., Karadag O., Maras Y., Kisacik B., et al.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, ss.4050-4051, (Özet Bildiri) identifier

133. A comparison of effects of active physiotheraphy and home exercise programs in patients with osteoarthritis of the shoulder

Yakut E., Yagli N. V., Kiraz S., Akdogan A., Kalyoncu U., Yakut Y., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.411, (Özet Bildiri) identifier

134. Drug transporter gene MDR1 polymorphism C3435T may explain colchicine nonresponsiveness in familial Mediterranean fever

Tufan A., Babaoglu M., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.100, (Özet Bildiri) identifier

135. Serum lipid changes and effect of colchicine on serum lipids in FMF

Akdogan A., Kalyoncu U., Tufan A., Karadag O., Calguneri M., Eren S., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.264, (Özet Bildiri) identifier

136. Anti TNF treatment may induce EBV reactivation in RA patients A clue for increased risk of lymphoma

TOKGÖZOĞLU S. L., ERTENLİ A. İ., KALYONCU U., ALP A., KARADAĞ Ö., ERMAN M., et al.
Annual European Congress of Rheumatology (EULAR 2006), 21 - 24 Haziran 2006, (Tam Metin Bildiri)

137. QT dispersion increases in patients with systemic lupus erythematosus

Yavuz B., Karadag O., Tulumen E., Calguneri M., Atalar E., Ovunc K., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237-238, (Özet Bildiri) identifier

138. B-type natriuretic peptide (BNP) is useful for detecting diastolic dysfunction in patients with systemic lupus erythematosus

Karadag O., Yavuz B., Calguneri M., Akdogan A., Atalar E., Ovunc K., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237, (Özet Bildiri) identifier

139. Novel cardiovascular risk factors and cardiac event predictors in systemic lupus erythematosus

Karadag O., Calguneri M., Yavuz B., Akdogan A., Atalar E., Kalyoncu U., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237, (Özet Bildiri) identifier

140. The correlations of plasma inflammatory markers and anti-nucleosome antibodies with SLEDAI

Kalyoncu U., Akdogan A., Calguneri M., Karadag O., Kisacik B., Apras S., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237, (Özet Bildiri) identifier

141. Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.

Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri) identifier

142. Neutrophil CD64 expression in Behqet's disease

Ureten K., Ertenli I., Calguneri M., Ozturk M., Onat A., Akdogan A., et al.
Annual European Congress of Rheumatology (EULAR 2004), Berlin, Almanya, 9 - 12 Haziran 2004, cilt.63, ss.316, (Özet Bildiri) identifier
Metrikler

Yayın

505

Yayın (WoS)

466

Yayın (Scopus)

346

Atıf (WoS)

3092

H-İndeks (WoS)

25

Atıf (Scopus)

4746

H-İndeks (Scopus)

32

Atıf (Scholar)

10759

H-İndeks (Scholar)

47

Atıf (TrDizin)

4

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

15

Proje

6

Tez Danışmanlığı

1

Açık Erişim

144
BM Sürdürülebilir Kalkınma Amaçları